We set up an interview with David Spetzler, the CSO of Caris Life Sciences, to hear about some promising new liquid biopsy tests they are developing.
Yes to FDA Regulation of LDTs, But We Need a New Framework, Says David Spetzler
Yes to FDA Regulation of LDTs, But We Need a…
Yes to FDA Regulation of LDTs, But We Need a New Framework, Says David Spetzler
We set up an interview with David Spetzler, the CSO of Caris Life Sciences, to hear about some promising new liquid biopsy tests they are developing.